CTGov Compliance My Organizations

Compliance Rate

Compliance Rate 0%

Compliant submissions 0

Incompliant submissions 0

Total trials 0

My Organizations' Clinical Trials

Showing 450 of 518 entries

View as:

Post-Approval Study of the Guidant Carotid Stent Systems and Embolic Protection Systems: CAPTURE

Phase: N/A Priority: Normal

NCT ID: NCT00180492 Org: User:

Start: 10/31/04 End: 08/31/07 Due: 08/31/08

ACCESS-Europe A Two-Phase Observational Study of the MitraClip® System in Europe

Phase: N/A Priority: Normal

NCT ID: NCT01288976 Org: User:

Start: 10/31/08 End: 08/31/12 Due: 08/31/13

Portico Valve-in-Valve Retrospective Registry

Phase: N/A Priority: Normal

NCT ID: NCT05002088 Org: User:

Start: 10/21/21 End: 12/29/23 Due: 12/29/24

Quartet Lead and Resynchronization Therapy Options

Phase: N/A Priority: Normal

NCT ID: NCT01295840 Org: User:

Start: 01/31/11 End: 09/30/12 Due: 09/30/13

Real World Study of the Tendyne™ Mitral Valve System to Treat Mitral Regurgitation

Phase: N/A Priority: Normal

NCT ID: NCT04818502 Org: User:

Start: 05/04/21 End: 05/31/29 Due: 05/31/30

Health App Data Collection Study

Phase: N/A Priority: Normal

NCT ID: NCT06595615 Org: User:

Start: 03/31/25 End: 12/31/27 Due: 12/31/28

A(f)MAZE-CABG Study

Phase: N/A Priority: Normal

NCT ID: NCT00735722 Org: User:

Start: 07/31/09 End: 08/31/12 Due: 08/31/13

XIENCE V Everolimus Eluting Coronary Stent System (EECSS) China: Post-Approval Randomized Control Trial (RCT)

Phase: N/A Priority: Normal

NCT ID: NCT01178268 Org: User:

Start: 08/31/10 End: 09/30/14 Due: 09/30/15

The LEADLESS II IDE Study for the Nanostim Leadless Pacemaker

Phase: N/A Priority: Normal

NCT ID: NCT02030418 Org: User:

Start: 02/28/14 End: 07/15/22 Due: 07/15/23

Randomized Evaluation of Redo Ablation Procedures of Atrial Fibrillation With FIRM Guided Procedures

Phase: N/A Priority: Normal

NCT ID: NCT02799043 Org: User:

Start: 06/30/16 End: 07/31/20 Due: 07/31/21

ESPRIT I: A Clinical Evaluation of the Abbott Vascular ESPRIT BVS (Bioresorbable Vascular Scaffold) System

Phase: N/A Priority: Normal

NCT ID: NCT01468974 Org: User:

Start: 11/30/11 End: 12/31/15 Due: 12/31/16

Clinical Evaluation of the Infinity Deep Brain Stimulation System

Phase: N/A Priority: Normal

NCT ID: NCT02989610 Org: User:

Start: 01/31/17 End: 04/19/22 Due: 04/19/23

Observational Study of OCT in a Patients Undergoing FFR

Phase: N/A Priority: Normal

NCT ID: NCT01663896 Org: User:

Start: 12/11/12 End: 10/31/15 Due: 10/31/16

XIENCE 90: A Safety Evaluation of 3-month DAPT After XIENCE Implantation for HBR Patients.

Phase: N/A Priority: Normal

NCT ID: NCT03218787 Org: User:

Start: 07/19/17 End: 09/04/20 Due: 09/04/21

Physiologic Pacing Registry

Phase: N/A Priority: Normal

NCT ID: NCT03719040 Org: User:

Start: 11/27/18 End: 10/07/21 Due: 10/07/22

Substrate and Trigger Ablation for Reduction of Atrial Fibrillation Trial - Star AF II Study

Phase: N/A Priority: Normal

NCT ID: NCT01203748 Org: User:

Start: 11/30/10 End: 01/31/14 Due: 01/31/15

A Prospective Clinical Outcomes Registry

Phase: N/A Priority: Normal

NCT ID: NCT01305525 Org: User:

Start: 06/30/09 End: 04/30/14 Due: 04/30/15

ABSORB III Randomized Controlled Trial (RCT)

Phase: N/A Priority: Normal

NCT ID: NCT01751906 Org: User:

Start: 12/31/12 End: 10/31/20 Due: 10/31/21

Selected Site Pacing to Avoid Phrenic Nerve Stimulation in Cardiac Resynchronization Patients With Quadripolar Left Ventricular Leads

Phase: N/A Priority: Normal

NCT ID: NCT01484613 Org: User:

Start: 11/30/11 End: 06/30/14 Due: 06/30/15

Thoratec's Reduce Driveline Trauma Through Stabilization and Exit Site Management Study

Phase: N/A Priority: Normal

NCT ID: NCT01485666 Org: User:

Start: 05/31/12 End: 08/31/13 Due: 08/31/14

Expanded Clinical Study of the Tendyne Mitral Valve System

Phase: N/A Priority: Normal

NCT ID: NCT02321514 Org: User:

Start: 11/30/14 End: 12/31/25 Due: 12/31/26

Evaluate St Jude Medical Prodigy Neuromodulation for FBSS or Chronic Pain of the Trunk and/or Limbs

Phase: N/A Priority: Normal

NCT ID: NCT02143791 Org: User:

Start: 06/30/14 End: 10/31/16 Due: 10/31/17

Quartet Lead and Resynchronization Therapy Options III (QUARTO_III)

Phase: N/A Priority: Normal

NCT ID: NCT02476201 Org: User:

Start: 02/29/16 End: 07/31/19 Due: 07/31/20

Safety and Effectiveness of TactiCath™ Contact Force, Sensor Enabled™ (TactiCath SE) Catheter for Ablation of Drug Refractory, Symptomatic, Persistent Atrial Fibrillation

Phase: N/A Priority: Normal

NCT ID: NCT03650556 Org: User:

Start: 09/28/18 End: 01/11/21 Due: 01/11/22

Evaluate the Safety and Efficacy of OAS in Treating Severely Calcified Coronary Lesions

Phase: N/A Priority: Normal

NCT ID: NCT01092416 Org: User:

Start: 05/31/10 End: 01/31/16 Due: 01/31/17

Title	NCT ID	Organization	User	Status	Start Date	End Date	Reporting Due Date	Last Checked	User Role	Org Created
Post-Approval Study of the Guidant Carotid Stent Systems and Embolic Protection Systems: CAPTURE	NCT00180492	Abbott Medical Devices	user2@example.com	None	2004-10-31	2007-08-31	2008-08-31	-	-	2025-07-14
ACCESS-Europe A Two-Phase Observational Study of the MitraClip® System in Europe	NCT01288976	Abbott Medical Devices	user2@example.com	None	2008-10-31	2012-08-31	2013-08-31	-	-	2025-07-14
Portico Valve-in-Valve Retrospective Registry	NCT05002088	Abbott Medical Devices	user2@example.com	None	2021-10-21	2023-12-29	2024-12-29	-	-	2025-07-14
Quartet Lead and Resynchronization Therapy Options	NCT01295840	Abbott Medical Devices	user2@example.com	None	2011-01-31	2012-09-30	2013-09-30	-	-	2025-07-14
Real World Study of the Tendyne™ Mitral Valve System to Treat Mitral Regurgitation	NCT04818502	Abbott Medical Devices	user2@example.com	None	2021-05-04	2029-05-31	2030-05-31	-	-	2025-07-14
Health App Data Collection Study	NCT06595615	Abbott Medical Devices	user2@example.com	None	2025-03-31	2027-12-31	2028-12-31	-	-	2025-07-14
A(f)MAZE-CABG Study	NCT00735722	Abbott Medical Devices	user2@example.com	None	2009-07-31	2012-08-31	2013-08-31	-	-	2025-07-14
XIENCE V Everolimus Eluting Coronary Stent System (EECSS) China: Post-Approval Randomized Control Trial (RCT)	NCT01178268	Abbott Medical Devices	user2@example.com	None	2010-08-31	2014-09-30	2015-09-30	-	-	2025-07-14
The LEADLESS II IDE Study for the Nanostim Leadless Pacemaker	NCT02030418	Abbott Medical Devices	user2@example.com	None	2014-02-28	2022-07-15	2023-07-15	-	-	2025-07-14
Randomized Evaluation of Redo Ablation Procedures of Atrial Fibrillation With FIRM Guided Procedures	NCT02799043	Abbott Medical Devices	user2@example.com	None	2016-06-30	2020-07-31	2021-07-31	-	-	2025-07-14
ESPRIT I: A Clinical Evaluation of the Abbott Vascular ESPRIT BVS (Bioresorbable Vascular Scaffold) System	NCT01468974	Abbott Medical Devices	user2@example.com	None	2011-11-30	2015-12-31	2016-12-31	-	-	2025-07-14
Clinical Evaluation of the Infinity Deep Brain Stimulation System	NCT02989610	Abbott Medical Devices	user2@example.com	None	2017-01-31	2022-04-19	2023-04-19	-	-	2025-07-14
Observational Study of OCT in a Patients Undergoing FFR	NCT01663896	Abbott Medical Devices	user2@example.com	None	2012-12-11	2015-10-31	2016-10-31	-	-	2025-07-14
XIENCE 90: A Safety Evaluation of 3-month DAPT After XIENCE Implantation for HBR Patients.	NCT03218787	Abbott Medical Devices	user2@example.com	None	2017-07-19	2020-09-04	2021-09-04	-	-	2025-07-14
Physiologic Pacing Registry	NCT03719040	Abbott Medical Devices	user2@example.com	None	2018-11-27	2021-10-07	2022-10-07	-	-	2025-07-14
Substrate and Trigger Ablation for Reduction of Atrial Fibrillation Trial - Star AF II Study	NCT01203748	Abbott Medical Devices	user2@example.com	None	2010-11-30	2014-01-31	2015-01-31	-	-	2025-07-14
A Prospective Clinical Outcomes Registry	NCT01305525	Abbott Medical Devices	user2@example.com	None	2009-06-30	2014-04-30	2015-04-30	-	-	2025-07-14
ABSORB III Randomized Controlled Trial (RCT)	NCT01751906	Abbott Medical Devices	user2@example.com	None	2012-12-31	2020-10-31	2021-10-31	-	-	2025-07-14
Selected Site Pacing to Avoid Phrenic Nerve Stimulation in Cardiac Resynchronization Patients With Quadripolar Left Ventricular Leads	NCT01484613	Abbott Medical Devices	user2@example.com	None	2011-11-30	2014-06-30	2015-06-30	-	-	2025-07-14
Thoratec's Reduce Driveline Trauma Through Stabilization and Exit Site Management Study	NCT01485666	Abbott Medical Devices	user2@example.com	None	2012-05-31	2013-08-31	2014-08-31	-	-	2025-07-14
Expanded Clinical Study of the Tendyne Mitral Valve System	NCT02321514	Abbott Medical Devices	user2@example.com	None	2014-11-30	2025-12-31	2026-12-31	-	-	2025-07-14
Evaluate St Jude Medical Prodigy Neuromodulation for FBSS or Chronic Pain of the Trunk and/or Limbs	NCT02143791	Abbott Medical Devices	user2@example.com	None	2014-06-30	2016-10-31	2017-10-31	-	-	2025-07-14
Quartet Lead and Resynchronization Therapy Options III (QUARTO_III)	NCT02476201	Abbott Medical Devices	user2@example.com	None	2016-02-29	2019-07-31	2020-07-31	-	-	2025-07-14
Safety and Effectiveness of TactiCath™ Contact Force, Sensor Enabled™ (TactiCath SE) Catheter for Ablation of Drug Refractory, Symptomatic, Persistent Atrial Fibrillation	NCT03650556	Abbott Medical Devices	user2@example.com	None	2018-09-28	2021-01-11	2022-01-11	-	-	2025-07-14
Evaluate the Safety and Efficacy of OAS in Treating Severely Calcified Coronary Lesions	NCT01092416	Abbott Medical Devices	user2@example.com	None	2010-05-31	2016-01-31	2017-01-31	-	-	2025-07-14

Compliance Rate

My Organizations' Clinical Trials

Appearance